Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Comprehensive Coagulopathy Workup

Essential Laboratory Testing

  • Lactate dehydrogenase (LDH) is a critical prognostic marker for various conditions including lymphoma and hemolysis 1
  • Thyroid function tests should be included as thyroid dysfunction can influence coagulation and cognitive function 2
  • Vitamin B12 and folate measurements are important to rule out deficiencies that can affect hematologic parameters 2, 3
  • Prothrombin time (PT/INR) and activated partial thromboplastin time (aPTT) should be included to evaluate the coagulation pathway 4

Advanced Coagulation Testing

  • Factor VIII and IX levels and von Willebrand activity should be considered, especially with unexplained bleeding or bruising 4
  • Advanced coagulation tests including factor XI and XIII levels may be necessary for thorough evaluation of bleeding disorders 4
  • Serum tryptase and vitamin B12 levels should be measured to evaluate for myeloproliferative disorders, particularly in patients with unexplained splenomegaly or eosinophilia 3

Specialized Testing Based on Clinical Suspicion

  • Flow cytometry of peripheral blood for immunophenotyping if lymphoproliferative disorder is suspected 1, 3
  • β2-microglobulin is an important prognostic marker for certain hematologic malignancies 1
  • Serum protein electrophoresis should be performed to evaluate for paraproteinemia 1
  • Testing for JAK2, CALR, and MPL mutations if myeloproliferative neoplasm is suspected 3

Imaging Considerations

  • Right upper quadrant abdominal ultrasonography should be performed to assess liver and spleen size and texture 3
  • Consider CT or MRI of the abdomen if ultrasound findings are equivocal or lymphadenopathy needs further characterization 3

Common Pitfalls to Avoid

  • Overlooking the need for bone marrow evaluation in patients with concerning peripheral blood findings 3

Follow-up Testing

  • For abnormal results, consider bone marrow aspiration and biopsy with immunohistochemistry, cytogenetics, and molecular testing if myeloproliferative or lymphoproliferative disorder is suspected 1, 3
  • Repeat testing may be necessary to monitor trends, especially for borderline abnormalities 5